Li Yuhuan, Wang Li-Xin, Yang Guojun, Hao Fang, Urba Walter J, Hu Hong-Ming
Laboratory of Cancer Immunobiology, Providence Portland Medical Center, OR 97213-2967, USA.
Cancer Res. 2008 Sep 1;68(17):6889-95. doi: 10.1158/0008-5472.CAN-08-0161.
Cross-presentation of antigens is critical for the induction of adaptive immunity against tumor cells and infectious pathogens. Currently, it is not known how cross-presentation of tumor antigens is regulated by autophagy. Using both HEK 293T cells that expressed the model antigen OVA and melanoma cells as antigen donors, we show that macroautophagy in tumor cells is essential for cross-presentation by dendritic cells both in vitro and in vivo. Inhibition of autophagy abolished cross-presentation almost completely, whereas induction of autophagy dramatically enhanced the cross-presentation of tumor antigens. Moreover, purified autophagosomes were found to be efficient antigen carriers for cross-presentation. Our findings not only identified a novel role for autophagy as an active process in antigen sequestration and delivery to dendritic cells for cross-presentation, but also suggested, for the first time, that isolated autophagosomes may have potential as potent vaccines for immunotherapy against cancer and infectious diseases.
抗原交叉呈递对于诱导针对肿瘤细胞和传染性病原体的适应性免疫至关重要。目前,尚不清楚自噬如何调节肿瘤抗原的交叉呈递。利用表达模型抗原OVA的HEK 293T细胞和黑色素瘤细胞作为抗原供体,我们发现肿瘤细胞中的巨自噬对于树突状细胞在体外和体内的交叉呈递至关重要。自噬抑制几乎完全消除了交叉呈递,而自噬诱导则显著增强了肿瘤抗原的交叉呈递。此外,纯化的自噬体被发现是用于交叉呈递的有效抗原载体。我们的发现不仅确定了自噬作为抗原隔离和递送至树突状细胞进行交叉呈递的活跃过程的新作用,还首次表明,分离的自噬体可能具有作为针对癌症和传染病免疫治疗的有效疫苗的潜力。